UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Versatile strategy for controlling the specificity and activity of engineered T cells

Proceedings of the National Academy of Sciences - PNAS, 2016-01, Vol.113 (4), p.E450-E458

2016

Volltextzugriff (PDF)

A Genetically Encoded aza-Michael Acceptor for Covalent Cross-Linking of Protein–Receptor Complexes

Journal of the American Chemical Society, 2014-06, Vol.136 (23), p.8411-8417

2014

Volltextzugriff (PDF)

New molecularly targeted therapies for lung cancer

The Journal of clinical investigation, 2007-10, Vol.117 (10), p.2740-2750

2007

Volltextzugriff (PDF)

Therapeutic Applications of an Expanded Genetic Code

Chembiochem : a European journal of chemical biology, 2014-08, Vol.15 (12), p.1721-1729

2014

Volltextzugriff (PDF)

Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing

Genetics in medicine, 2020-11, Vol.22 (11), p.1892-1897

2020

Volltextzugriff (PDF)

Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer

Current oncology (Toronto), 2023-07, Vol.30 (8), p.7099-7111

2023

Volltextzugriff (PDF)

Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach

Health expectations : an international journal of public participation in health care and health policy, 2023-04, Vol.26 (2), p.774-784

2023

Volltextzugriff (PDF)

Less Toxic Chemotherapy Improves Uptake of All Lines of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A 10-Year Retrospective Population-Based Review

Journal of thoracic oncology, 2014-08, Vol.9 (8), p.1180-1186

2014

Volltextzugriff (PDF)

Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing

PloS one, 2015-03, Vol.10 (3), p.e0119689-e0119689

2015

Volltextzugriff (PDF)

Location matters: cellular heterogeneity in the hepatic lobule and hepatocellular carcinoma

American journal of physiology: Gastrointestinal and liver physiology, 2023-04, Vol.324 (4), p.G245-G249

2023

Volltextzugriff (PDF)

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening

Cancer medicine (Malden, MA), 2020-06, Vol.9 (11), p.4004-4013

2020

Volltextzugriff (PDF)

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers

Cancer medicine (Malden, MA), 2021-08, Vol.10 (15), p.5131-5140

2021

Volltextzugriff (PDF)

Rapid Intestinal Uptake and Targeted Delivery to the Liver Endothelium Using Orally Administered Silver Sulfide Quantum Dots

ACS nano, 2020-02, Vol.14 (2), p.1492-1507

2020

Volltextzugriff (PDF)

Lung cancer in never smokers - a different disease

Nature reviews. Cancer, 2007-10, Vol.7 (10), p.778-790

2007

Volltextzugriff (PDF)

Acknowledging Disparities in Hereditary Cancer Testing

Journal of clinical oncology, 2021-12, Vol.39 (36), p.4001-4003

2021

Volltextzugriff (PDF)

Balancing uncertainty with patient autonomy in precision medicine

Nature reviews. Genetics, 2019-05, Vol.20 (5), p.251-252

2019

Volltextzugriff (PDF)

What competencies do European general practice trainees value the most? A prioritisation exercise using a Delphi-informed approach

Education for primary care, 2023-07, Vol.34 (4), p.192-198

2023

Volltextzugriff (PDF)

High-Ambient Air Pollution Exposure Among Never Smokers Versus Ever Smokers With Lung Cancer

Journal of thoracic oncology, 2021-11, Vol.16 (11), p.1850-1858

2021

Volltextzugriff (PDF)

Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trial

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107529, Article 107529

2024

Volltextzugriff (PDF)

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Clinical cancer research, 2021-01, Vol.27 (1), p.202-212

2021

Volltextzugriff (PDF)

Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)

Journal of thoracic oncology, 2023-08, Vol.18 (8), p.1031-1041

2023

Volltextzugriff (PDF)

Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer

Journal of clinical oncology, 2016-03, Vol.34 (8), p.810-815

2016

Volltextzugriff (PDF)

Willingness of breast cancer patients to undergo biopsy and breast cancer clinicians’ practices around seeking biopsy at the time of breast cancer relapse

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.221-228

2018

Volltextzugriff (PDF)

An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool

Cancer, 2021-09, Vol.127 (17), p.3183-3193

2021

Volltextzugriff (PDF)

Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing

European journal of human genetics : EJHG, 2023-05, Vol.31 (5), p.602-606

2023

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(180)

Publikationsform

Artikel
(210)

Sprache

Englisch
(210)

Erscheinungsjahr

n.n

Thema

Science & Technology
(197)
Life Sciences & Biomedicine
(171)
Female
(92)
Male
(72)
Adult
(54)
Middle Aged
(52)
Aged
(41)
Oncology
(41)
Animals
(37)
Covid-19
(31)
Mice
(26)
Child
(25)
Sars-Cov-2
(24)
Science & Technology - Other Topics
(23)
Young Adult
(23)
Multidisciplinary Sciences
(22)
Patients
(22)
Severe Acute Respiratory Syndrome Coronavirus 2
(21)
Life Sciences
(20)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Versatile strategy for controlling the specificity and activity of engineered T cells

A Genetically Encoded aza-Michael Acceptor for Covalent Cross-Linking of Protein–Receptor Complexes

New molecularly targeted therapies for lung cancer

Therapeutic Applications of an Expanded Genetic Code

Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing

Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer

Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach

Less Toxic Chemotherapy Improves Uptake of All Lines of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A 10-Year Retrospective Population-Based Review

Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing

Location matters: cellular heterogeneity in the hepatic lobule and hepatocellular carcinoma

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers

Rapid Intestinal Uptake and Targeted Delivery to the Liver Endothelium Using Orally Administered Silver Sulfide Quantum Dots

Lung cancer in never smokers - a different disease

Acknowledging Disparities in Hereditary Cancer Testing

Balancing uncertainty with patient autonomy in precision medicine

What competencies do European general practice trainees value the most? A prioritisation exercise using a Delphi-informed approach

High-Ambient Air Pollution Exposure Among Never Smokers Versus Ever Smokers With Lung Cancer

Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trial

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)

Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer

Willingness of breast cancer patients to undergo biopsy and breast cancer clinicians’ practices around seeking biopsy at the time of breast cancer relapse

An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool

Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing

Aktive Filter

Suchergebnisse filtern